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In the knee, menisci are important fibrocartilaginous struc-
tures contributing to distribute the weight across the joint.
The major collagen of the meniscus is type I, but types II,
III, V and VI collagens are minor constituents.1 In addition,
a recent study has shown type X collagen deposition in
mouse articular cartilage and menisci, particularly in
degenerating menisci.2 Type X collagen was originally
thought to be restricted to hypertrophic chondrocytes of the
growth plate,3 but more recent studies have demonstrated
the occurrence of type X collagen at the surface of normal
human, porcine and rat articular cartilage,4 in the fracture
callus of normal canine articular cartilage5 and in human
osteoarthritic cartilage.6 Moreover, type X collagen has
been identified in human intervertebral disc, particularly
during degeneration.7 Taken together, these results
suggest that type X collagen may contribute to the
structural maintenance of articular and fibrocartilage.
Osteoarthritis (OA) is a common disease that affects the
joints. It occurs frequently in the knee, where both articular
cartilage and meniscus show degenerative lesions. So far,
most studies on OA have focused on articular cartilage;
only a few attempts have been made to survey evolution of
meniscus, particularly in animal models. In the first place,
this report provides the evidence that type X collagen is a
natural component of human and rabbit meniscus and
extends the recent identification of this protein in mouse
meniscus.2 To supplement our knowledge of type X colla-
gen in human non hypertrophic cartilage, and its possible
involvement in OA, we used Western blotting and RT-PCR
analyses to study type X collagen expression in normal
menisci and in degenerative menisci from OA patients.
Indeed, our data revealed the presence of this protein in
normal and OA menisci. Furthermore, RT-PCR analysis
performed on RNA extracted from normal and OA menisci498showed an increase in type X collagen expression in the
degenerative menisci.Methods
RABBIT AND HUMAN SAMPLES
Rabbit samples: Rabbits Gris de Champagne were 8
months of age and skeletally mature. Animals were killed
and menisci that looked macroscopically normal were
analysed.
Human samples: three menisci (A, C, D) were obtained
from individuals (aged 42, 27, 36 years, respectively)
operated for an anterior cruciate ligament surgery. These
menisci looked macroscopically normal. One normal
meniscus in appearance (E1) and one meniscus displaying
degenerative lesions (E2) were taken from the same articu-
lation of a 74-year-old patient undergoing total knee
replacement. Three menisci with degenerative lesions (B,
F, G) were collected from patients aged >70 years under-
going total knee replacement. The articular cartilages of
these patients were osteoarthritic in appearance.
The rabbit and human samples were frozen into liquid
nitrogen and powdered with mortar and pestle, for protein
or RNA extraction.Received 28 October 1998; accepted 4 March 1999.
Address correspondence to: Dr Frederic Mallein-Gerin, Institut
de Biologie et Chimie des Prote´ines, 7 passage du Vercors, 69367
Lyon Cedex 07, France.REVERSE TRANSCRIPTION-PCR (RT-PCR)
Total RNA was isolated by using a modification of the
guanidinium isothiocyanate (GIT) procedure.8 After phenol-
chloroform extraction and precipitation, the pellet was
resuspended in 1M GIT with 200 ìg/ml Proteinase K, and
incubated at 40°C until complete dissolution. The GIT
concentration was then adjusted to 4M and the sample was
layered on a cushion of cesium trifluoroacetate (CsTFA)
with a density of 1.6 g/ml, for ultracentrifugation. For the
reverse transcription, a 40 ìl reaction contained 1.5 ìg of
total RNA, 24 ìM oligo-dT primers, 125 ìM each dNTP and
400 units of reverse transcriptase (SuperScript II RNAse
H-; GIBCO BRL). The reaction was carried out at 42°C for
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50 ìl reaction contained 5 ìM each dNTP, 0.8 ìM each
specific primer, 2.5 units of Taq DNA polymerase (Perkin
Elmer), 10 ìl RT reaction for MMP-1 and 2 ìl RT reaction
for the other markers. Specific primers were designed for
amplification of type X and type II collagen, MMP-1,
MMP-3, TIMP-1 and GAPDH (see Fig. 2a). Thirty to forty
cycles were employed, with denaturation at 94°C for 1 min,
annealing at optimal temperature (see Fig. 2a) for 30 s, and
extension at 72°C for 45 s. The PCR products were elec-
trophoresed in a 2% agarose gel and the bands were
stained with ethidium bromide and visualized under ultra-
violet light. The PCR products eluted from the gels were
cloned in a TA cloning vector (Invitrogen, San Diego, CA)
and sequenced.COLLAGEN EXTRACTION AND WESTERN BLOTTING
Frozen and powdered tissues were extracted in 4M
guanidinium chloride (GuCl) buffer. The remaining residue
was washed and treated with pepsin at 1:10 (w/w pepsin to
tissue wet weight). After 24 h with stirring at 4°C, the pepsin
digests were centrifuged and the collagens recovered in
the acidic solution were separated by NaCl fractionation.9
The proteins were resolved by SDS-PAGE. Gels were
stained with Coomassie blue or transferred to nitrocellulose
membrane for Western blotting with the anti-type X colla-
gen antibodies: (i) rabbit fractions were allowed to react
with a polyclonal antibody raised in mice against deer type
X collagen, a gift of Dr G. J. Gibson (Breeche Research
Laboratories, Detroit, MI); (ii) human fractions were allowed
to react with a mouse monoclonal antibody (X53) againsthuman type X collagen.10 The membranes were then
incubated with biotinylated horse anti-mouse IgG (Vector
Laboratories, Burlingame, CA). Following several PBS-
Tween washes, the membranes were treated with an
avidin–biotin horseradish peroxydase complex (Vectastain
ABC kit, Vector Laboratories), washed with PBS-Tween
and developed with a 4-chloro-1-naphtol/H2O2 solution.Fig. 1. (a) On the left: SDS-8% polyacrylamide gel electrophoresis of rabbit meniscus proteins stained with Coomassie blue. A molecular
weight marker is shown on lane 1. After GuCl extraction, solubilized proteins were precipitated with 3M NaCl (lane 2). The unsolubilized
residue was pepsinized, collagens were separated by salt fractionation and the 0.86M NaCl fraction is shown on lane 3. On the right:
Western-blotting of a gel equivalent to that shown on the left, with a polyclonal antibody against deer type X collagen. In the GuCl fraction
(lane 2), note the presence of a unique band reactive with the antibody and migrating with a molecular weight corresponding to Æ1(X) chains.
The same results were obtained with menisci from four different rabbits. (b) Western-blotting of proteins solubilized in GuCl and isolated from
a normal human meniscus (A) and from a degenerative meniscus of an OA patient (B), with a monoclonal antibody against human type X
collagen.Results/Discussion
Previous observations have shown the presence of
types I, II, III and V collagens in menisci of 8-month-old
rabbits.1 Our Western-blotting analysis revealed that at the
same stage, type X collagen is also a normal constituent of
rabbit meniscus (Fig. 1a). Experimental OA is commonly
performed in rabbit and this reproducible model should help
to clarify the role of this collagen in the normal and
degenerative meniscus. Furthermore, we detected by
immunoblotting type X collagen in one normal and in one
OA human meniscus (Fig. 1b), and this prompted us to
analyse type X collagen expression in other human
menisci.
For our preliminary analyses of gene expression in
human menisci, we used classical protocols described in
the litterature for RNA extraction from cartilage. We
obtained extremely low yields of RNA and our PCR ampli-
fication reactions were poorly reproducible, most likely
because of contamination by remaining proteoglycans. We
found that a treatment by proteinase K in 1M GIT prior to
CsTFA ultracentrifugation, was crucial to increase the yield
and purity of RNA. This led indeed in reproducible patterns
of PCR after reverse transcription of minute amounts of
500 G. Bluteau et al.: Type X collagen in meniscus(a)
Molecule Primers Strand Location Product
size
Annealing
temperature
Source
Type X collagen GCCTGAGGGTTTTATAAAGG + 1505–1525 501 bp 53°C emb X72580
TTAGCTCTGTGGGGTGTAC − 2006–1988
Type II collagen ATCGACATGTCCGCCTTTGCT + 130–150 618 bp 53°C emb X06268
TGCCCGGATCTCCACGTCATT − 747–727
MMP-1 GGTATGATGAATATAAACG + 1264–1282 205 bp 47°C emb X54925
CTGCAGTTGAACCAGCT − 410–394
MMP-3 GGCCATCTCTTCCTTCAG + 1041–1058 400 bp 52°C gb J03209
GTCACTTTCTTTGCATTTGG − 1440–1421
TIMP-1 TACACCCCCGCCATGG + 315–330 260 bp 49°C emb X03124
GTCCACAAGCAATGAGTG − 574–557
GAPDH ATCACTGCCACCCAGAAGAC + 601–620 443 bp 57°C gb M33197
ATGAGGTCCACCACCCTGTT − 1043–1024
Fig. 2. (a) Oligonucleotide primers used for comparative PCR analysis. Primers are presented in a 5 ¢ to 3¢ orientation, with that for the coding
strand (+) being above that for the non-coding strand (−). The location of each primer within the corresponding cDNA sequence is indicated,
together with the product size generated by reverse transcription and PCR amplification of the mRNA. The annealing temperature used for
each primer set, and the source of the databank used for designing the primers, are also listed. (b) RT-PCR analysis of mRNA expression
in normal human menisci (C, D) and in degenerative menisci from OA patients (F, G). E1 represents a normal meniscus and E2 a
degenerative meniscus isolated from the same articulation of an OA patient. After ultracentrifugation, total RNA was digested with
RNAse-free DNAse, phenol-chloroform extracted, precipitated and reverse-transcribed into cDNA, followed by a PCR reaction using specific
primer pairs listed in Fig. 2a. The gene products analyzed are indicated on the left. The specificity of the amplified products was confirmed
by automatic nucleotide sequencing (ESGS, France). Type X collagen expression was barely detectable in C, C* represents a PCR reaction
started with a 5 fold volume of RT reaction in comparison with C.
Osteoarthritis and Cartilage Vol. 7 No. 5 501RNA, which is particularly convenient for human samples
difficult to obtain in high quantities.
In the view of determining variation of a given message
between normal and degenerative menisci, message for
the glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
gene was used to ascertain that an equivalent amount of
cDNA was synthesized from the different tissues. This is
based on the assumption that the message for this house-
keeping gene remains relatively constant on a per cell
basis. We indeed obtained nearly the same level of mes-
sage for the GAPDH gene, as judged by ethidium bromide
staining (Fig. 2b). The PCR signals obtained after amplifi-
cation of the type X collagen message were stronger in the
OA menisci in comparison with the normal menisci, and
interestingly, this difference was observed between two
menisci of the same articulation (see Fig. 2b, samples E1
and E2). Although our RT-PCR reactions were performed
under qualitative rather than quantitative conditions, our
results suggest that type X collagen expression increases
with degeneration of meniscus, and this is in accordance
with the strong immunohistochemical staining of type X
collagen observed in menisci of mice harboring OA.2 At the
same time, type II collagen was clearly detected in all
samples, attesting the cartilage nature of these tissues. In
order to gain more information on the phenotype of the
menisci under study, we further compared gene expression
of two matrix metalloproteinases (MMPs) thought to be
involved in cartilage degradation. MMP-3 was expressed in
all samples whereas MMP-1 gene expression was barely
detectable, except in one OA meniscus where the PCR
signal was clearly higher (see Fig. 2b, sample G). These
results are in accordance with other observations showing
that these MMPs can be differentially regulated in human
OA articular cartilage.11,12 Furthermore, we found that
the level of gene expression of the tissue inhibitor of
metalloprotease-1 (TIMP-1) was equivalent in the normal
and degenerative meniscus (Fig. 2a). The relatively higher
expression of MMP-1 in one OA meniscus (sample G)
suggests that matrix degradation in degenerative meniscus
could be promoted by an imbalance between the level of
MMPs and their inhibitors, like it was hypothesized in the
case of human OA articular cartilage.13
MMPs and most likely other mediators contribute to the
heterogenous background of OA: molecular genetic analy-
ses of human patients or transgenic mice have revealed
that mutations in types II, IX and XI collagens can predis-
pose to OA.14 In regard of type X collagen, further studies
need to be done to investigate the role of this protein in
the structure of the meniscus in normal and pathological
conditions.
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